• Serialization/Track and Trace
  • Careers
  • Anti-Capital Punishment Statement
  • Contact Us
  • Online Ordering Portal
  • zoledronicpremix.com
  • glydo.com
Sagent PharmaceuticalsSagent Pharmaceuticals
Sagent Pharmaceuticals
  • Home
  • About
    • Our Executive Team
    • Who We Are
    • What We Do
    • Why We Do It
  • Products
  • PreventIV Measures®
Home > OXACILLIN for Injection, USP Recall Information

OXACILLIN for Injection, USP Recall Information

Customer Notification / Recall Communication Letter – OXACILLIN for Injection, USP (Lot OXT515. June 13, 2016)

Customer Recall Return Response Form – OXACILLIN for Injection, USP (Lot OXT515. June 13, 2016)

sagentadmin | Jun 14, 2016 | Sagent |

« FLUCONAZOLE Injection, USP in 0.9% Sodium Chloride Recall Information OXACILLIN for Injection, USP Recall Information »
www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals.
© 2023 Sagent Pharmaceuticals